All compounds are supplied for personal research purposes only and are not approved for human therapeutic use by any regulatory authority. By submitting an enquiry you confirm your understanding of this research-only status.

The reusable pen has a 60-click graduated barrel. 30 clicks = 0.303ml — exactly one tenth of a vial. 300 clicks empties a 3.03ml vial. Each click is precise and consistent. Prime the pen before first use by expelling a small amount before the first injection.

Note: every compound uses the same 3.03ml fill. Because 300 clicks empties a vial, a 30-click dose gives 10 doses per vial — and dose is simply vial strength × clicks ÷ 300.

Insert the pen needle through the vial septum. Pull the plunger back slowly to the desired click count. Withdraw the needle, tap out any air bubbles, and expel a small amount to confirm flow before injecting. Store the loaded pen tip-down in the refrigerator if not using immediately.

30 clicks = 0.303ml · 300 clicks = 3.03ml = 1 vial · 0.9% BAC water

GLP3-Plus (Retatrutide / LY3437943) simultaneously activates GLP-1, GIP, and glucagon receptors — a triple agonist. Phase 2 trial data: 22.8% mean body weight loss at 8mg/week over 48 weeks.

The protocol runs across three vials over approximately 10 weeks to reach the Phase 2 maintenance dose, then transitions to a monthly subscription:

Blood sugar caution: GLP3-Plus is a GLP-1/GIP/glucagon triple agonist and can lower blood glucose, particularly at higher doses or with reduced food intake. Keep a fast-acting glucose source on hand — MG-LZ8 Honey Snap Pack is recommended specifically for this: a natural, portable glucose source for if symptoms of low blood sugar appear.

It depends on the compound and your dosing frequency. Here are the typical requirements — full detail is in the Protocols tab:

MOTS-c is a 16-amino-acid peptide encoded directly in the mitochondrial genome. It activates AMPK — the master metabolic regulator — improving insulin sensitivity, metabolic flexibility, and exercise capacity. Research focus: metabolic recalibration, energy utilisation, longevity signalling. No completed human clinical trials to date — dosing is extrapolated from preclinical models.

BPC-157 is a 15-amino-acid peptide derived from a protective gastric juice protein. It promotes healing across multiple tissue types — gut wall repair, tendon and ligament regeneration, muscle recovery, and angiogenesis via VEGFR2 upregulation. Inject near the injury site where possible. For acute injury: twice daily. For maintenance or gut support: once daily.

TB-500 is a synthetic analogue of Thymosin Beta-4. It promotes actin polymerisation — enabling cell migration to injury sites — accelerating repair across muscle, tendon, ligament, skin, and cardiac tissue. Works systemically: injection site does not need to be near the injury. Often stacked with BPC-157 for comprehensive repair coverage.

SS-31 (Elamipretide) concentrates in the inner mitochondrial membrane, binding cardiolipin — critical to the electron transport chain. It stabilises crista architecture, reduces mitochondrial ROS, and restores ATP production efficiency. FDA granted accelerated approval in 2025 for Barth syndrome — the first approved mitochondrial membrane-targeted therapy.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) activates over 4,000 human genes, the majority involved in tissue repair, collagen synthesis, anti-inflammatory regulation, and antioxidant defence. Plasma levels decline from ~200ng/ml at age 20 to under 80ng/ml by age 60. Note: at FRC concentration (16.50mg/ml) a full 30-click dose delivers 5mg — use 6 clicks (1mg) or 12 clicks (2mg) for introductory dosing.

Ipamorelin is a pentapeptide ghrelin mimetic that selectively stimulates natural growth hormone release without raising cortisol, ACTH, or prolactin — even at high doses. Half-life approximately 2 hours. Administered pre-fasted AM and PM, spaced 10–12 hours apart. Titrate from 100mcg (15 clicks) to 200mcg (30 clicks). 5 vials per month at maintenance dosing.

NAD+ is the master coenzyme of cellular energy metabolism, central to over 500 enzymatic reactions and the essential cofactor for sirtuins (SIRT1–7) governing DNA repair, circadian rhythm, and cellular senescence. NAD+ levels decline by approximately 50% between ages 40 and 60.

GanodermaGOLD™ is built on MG-LZ8 — a proprietary Ganoderma sichuanense dual-phase extract that acts as a biological signal calibrator. Chronic inflammation and elevated cortisol create noise that disrupts immune communication. MG-LZ8 lowers that noise floor by supplying 5 of the 8 essential glyconutrients that build the glycoproteins immune cells use to signal each other.

Stacked with peptides, it ensures the signalling environment is clean enough for peptide instructions to land clearly. Particularly relevant with GLP3-Plus — reducing inflammatory baseline before starting a metabolic protocol improves response consistency significantly.

The noise reduction is genuinely dramatic, not a marginal effect. Pre-clinical data (Vetvicka, University of Louisville, 2018) recorded IL-2 cytokine production rising from 1.1 to 262.4 pg/ml at 100μg — a 238× increase, alongside phagocytosing neutrophils rising from a 31.1% baseline to 47.2% within 24 hours (+51.7%). Zero cytotoxicity was confirmed across four separate cancer cell lines at all doses tested. Prof. Vetvicka is the world's leading researcher in beta-glucan immunology, with over 300 peer-reviewed publications on immune modulation.

On safety specifically: no lethal dose has been established for MG-LZ8 (LD50 = 0) — testing has not identified a dose at which toxicity occurs. Independent heavy metals analysis confirmed all heavy metals below the limit of detection, with zero detectable starch and zero pathogens.

One genuine consideration: MG-LZ8 contains a fibrinolytic enzyme (Mr 52,000) with natural blood-thinning activity. If you are on a pharmaceutical anticoagulant (warfarin, heparin, aspirin therapy), consult your prescribing physician before use. All other concurrent use is generally safe — this is a consideration to be aware of, not a barrier to daily use.

TTD is the maximum-strength format in the MG-LZ8 range — a high-potency liquid concentrate carried by a pharmaceutical-grade DMSO base with patented CHD-FA™ fulvic acid, delivering 2.4g of MG-LZ8 per 30ml bottle directly into the bloodstream, bypassing digestive degradation entirely.

Chronic inflammation and elevated cortisol create biological noise that disrupts how immune cells communicate. MG-LZ8 lowers that noise floor by supplying 5 of the 8 essential glyconutrients (mannose, fucose, xylose, glucose, galactose) — the literal building blocks of the glycoproteins and glycoforms cells use to signal each other. These structures are recognised by Dectin-1 and Toll-like receptors on innate immune cells, converting a structural signal into an active response. This is the FirstSignal principle: a clearer signal, less noise, more coherent biological communication.

Independently validated pre-clinical data (Vetvicka, University of Louisville, 2018): phagocytosing neutrophils rose from a 31.1% baseline to 47.2% within 24 hours (+51.7%), alongside a 238× increase in IL-2 signalling, with zero cytotoxicity recorded.

Capsules are the daily oral foundation of the MG-LZ8 range — the simplest entry point, and the recommended starting layer to run alongside any peptide protocol. Each 15mg capsule is concentrated from a 12× more potent Antler-grown source with a further 29-fold dual-extraction yield, equal to 5,400mg of standard imported Reishi powder.

The mechanism is the same across the whole range: chronic inflammation and cortisol create biological noise that interferes with immune signalling. MG-LZ8 supplies 5 of the 8 essential glyconutrients that build the glycoproteins and glycoforms cells use to communicate, recognised through the Dectin-1 and TLR pathway — lowering the noise floor so the body's own signalling — its FirstSignal — comes through clearly.

Pre-clinical data (Vetvicka, 2018) recorded a +51.7% rise in phagocytosing neutrophils and a 238× increase in IL-2 signalling, with zero cytotoxicity. One capsule daily, systemic support.

The same noise-reducing MG-LZ8 mechanism as the rest of the range, in a mess-free single-serving format — 8mg of MG-LZ8 dual extract per 7g pack, paired with pure, naturally settled Cape Eucalyptus honey. Snap, squeeze into the mouth or a beverage, no water required.

MG-LZ8 supplies 5 of the 8 essential glyconutrients (mannose, fucose, xylose, glucose, galactose) that build the glycoproteins and glycoforms driving cell-to-cell communication, recognised via the Dectin-1/TLR pathway — the same +51.7% neutrophil activation and 238× IL-2 response documented across the range (Vetvicka, 2018). A practical first step into the range, or a convenient travel companion for existing researchers. Vegan, organic, non-GMO.

GLP3-Plus companion: if you're running a GLP3-Plus protocol, keep a pack on hand — a natural, fast-acting glucose source for if symptoms of low blood sugar appear.

The Skin Serum is a medical-grade transdermal topical — not a cosmetic product. A 20% pharmaceutical-grade DMSO carrier transports 24mg of MG-LZ8 Antler Reishi dual extract directly through the skin barrier into the lymphatic system and cellular tissue.

For peptide users specifically: people using this product report that subcutaneous bumps and nodules from sub-cut injections — often caused by particulate (“noise”) in the injected liquid — visibly reduce with regular use, with firmer, longer-standing bumps reported reduced to roughly 10% of original size after about 4 weeks. These bumps can otherwise persist for months, or never fully resolve on their own.

Beyond injection site recovery, reported uses include lymphatic support (congested or swollen nodes), joint and nerve inflammation, advanced wound care, and dermatological recovery. Apply 1–2 pumps directly to the affected area and allow to dry fully.

The serums are topical leave-on formulations, applied to skin rather than injected. They share one base — sodium hyaluronate at 0.5% in autoclaved distilled water, preserved with a phenoxyethanol and caprylyl glycol system — and differ by which actives they carry. All are filled into airless pumps, so the contents never meet air across the life of the bottle. They are regulated differently from the research compounds, which is why they sit in their own range.

A single-peptide serum carrying acetyl octapeptide-3 (Snap-8) at 0.008%. Snap-8 is an eight-amino-acid fragment modelled on SNAP-25, competing for its position in the SNARE complex and attenuating catecholamine release at the neuromuscular junction — the same target as botulinum approaches, by competitive inhibition rather than proteolytic cleavage. 30ml airless pump, two to three drops morning and evening.

A copper peptide serum carrying GHK-Cu at 0.5%. GHK-Cu is a copper-binding tripeptide occurring naturally in human plasma, where levels fall by roughly 60% between age twenty and sixty. Gene expression studies report upregulation of collagen I, III and IV and restored balance between matrix metalloproteinases and their inhibitors, with copper acting as the lysyl oxidase cofactor. Carries no chelating agent, since a chelator would compete for the copper. 30ml, evening application.

The flagship, carrying both Snap-8 at 0.008% and GHK-Cu at 0.5%. The two work on unrelated pathways — one presynaptic at the SNARE complex, the other transcriptional on the collagen matrix — so neither competes with the other. It is the most demanding batch to make: Snap-8 arrives as a trifluoroacetate salt and pulls the batch acidic, which is exactly where the copper complex is least stable, so pH is measured and corrected between additions. 30ml, evening.

A copper peptide serum for scalp and hairline rather than face, carrying AHK-Cu at 0.5%. AHK-Cu is closely related to GHK-Cu with alanine substituted at the N-terminal. Interest rests on reported VEGF upregulation in dermal papilla cells, since perifollicular vascularisation correlates with anagen duration. Held at 0.5% rather than the more common 1% — scalp skin is thinner and more vascular, and 1% copper preparations can sting. Applied to towel-dry hair.

The crossover between the two halves of the range — Snap-8 from the peptide side and MG-LZ8™ Ganoderma extract from the natural side, in one hydrating base. MG-LZ8 is a 110 amino acid fungal immunomodulatory protein acting on glycoform signalling. The extract enters as a liquid at 10% of batch, which changes the finished volume, so everything else is dosed against the final total. 30ml, morning and evening.

MG-LZ8™ in a DMSO carrier rather than a water base, with a hydrating gel body. DMSO transiently reorganises the lipid lamellae of the stratum corneum, admitting molecules that would otherwise stay on the surface — and it carries whatever is dissolved in it without selectivity, which is why nothing unnecessary is in the formulation. Namibian myrrh at 0.15% is dissolved into the DMSO first, needing no solubiliser. 50ml, applied sparingly to clean dry skin.

The MG-LZ8™ Skin Serum thinned onto a hydrating gel base — three parts original to one part base, bringing DMSO from 20% down to 15%. The dilution is about spread and feel rather than strength: neat, the serum is dense and best used sparingly on a small area; on the gel base it goes further and absorbs evenly, so it suits wider application. The undiluted Skin Serum remains available separately for targeted use. 50ml.

Semax is a synthetic heptapeptide — the ACTH(4–10) fragment with a Pro-Gly-Pro tail added. That tail is the whole design: the native fragment is broken down by serum peptidases within minutes, and the addition makes intranasal delivery viable. It has no corticotropic activity, so it does not raise cortisol. Reported activity centres on BDNF and NGF expression. Developed at the Russian Academy of Sciences and a registered medicine in Russia since the mid-1990s — though SAHPRA has not assessed it, and it is supplied here for research purposes only.

Two to three drops to clean skin for the 30ml face serums, morning or evening as listed on each. Follicular goes onto towel-dry hair at the scalp. FirstGlow and Defend are applied sparingly and allowed to absorb. All are preserved and stable at room temperature, kept out of direct sunlight. Semax is different — it is preservative-free, so it is short-dated and must be refrigerated at 2–8°C.

Unopened (lyophilised): refrigerate at 2–8°C. Keep away from direct light. Do not freeze.
After reconstitution: refrigerate at 2–8°C. Use within 4–6 weeks. Do not freeze the reconstituted solution — this degrades the peptide.
Allow vials to reach room temperature before opening to reduce condensation. Store the loaded pen tip-down in the fridge between doses.

Submit your selection using the enquiry form below. You will receive an invoice with EFT banking details and a reference number.

Your order is picked and packed on receipt of payment, then booked with a courier. Delivery is free on orders of R1,000 or more — below that, standard delivery rates apply.